Tags:CenterHealthTechHumanLifeMedTechResearchScienceUniversity
Amniotics AB are developing innovative stem cell-based therapeutics to treat severe life-threatening diseases, where effective treatment is lacking or is insufficient
Member count: 11-50
Total raised: $6.977596M
Founded date: 2015

Investors 1

DateNameWebsite
-Almi Inves...almi.se

Funding Rounds 1

DateSeriesAmountInvestorsDeal News
12.07.2021IPO$6.977596M-news.cisio...

Mentions in press and media 7

DateTitleDescriptionCategoryAuthorSource
20.01.2022Amniotics ...Amniotics AB (publ) announced ...--marketscre...
20.01.2022Amniotics ...Amniotics AB (publ) (Nasdaq St...--marketscre...
12.11.2021Interim Re...Preparing for clinical phase ...--marketscre...
27.08.2021Amniotics ...Successful IPO April - June i...--marketscre...
12.07.2021Stem cell ...Novel source of stem cells in ...--en.prnasia...
12.07.2021Stem cell ...Stem cell therapy company Amni...--news.cisio...
12.07.2021Amniotics ...LUND, Sweden, July 12, 2021 /P...--marketscre...